Literature DB >> 8638240

Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients?

K Mizoi1, T Kayama, T Yoshimoto, Y Nagamine.   

Abstract

BACKGROUND: It is generally accepted that excellent development of collateral circulation can be achieved through indirect nonanastomotic bypass procedures for pediatric patients with moyamoya disease. However, there are no definitive conclusions about the effect of indirect revascularization for adult patients. To clarify the value of indirect bypass surgery for adult moyamoya disease, we have analyzed their follow-up angiographic results in comparison with those of the pediatric patients.
METHODS: Between 1989 and 1993, 23 patients underwent combined direct and indirect bypass surgery. They consisted of 16 adults (mean age, 35; range, 20-59) and seven children (mean age, 10; range, 3-16). The main symptoms were those due to cerebral ischemia in all but 1 of 23 patients. Preoperative cerebral blood flow studies showed all patients to have decreased vascular reserve (misery perfusion). Postoperative follow-up angiography was done in all patients at a median of 6 months after the surgery.
RESULTS: All pediatric patients showed good or moderate development of collaterals through the indirect bypass. Among the adult group, seven patients aged 20 to 29 had angiographic results similar to those of the pediatric group . On the other hand, nine patients older than 30 had results contrary to those of pediatric patients: (1) the degree of indirect revascularization declined to moderate or poor grades (especially in patients older than 40) and (2) the degree of direct bypass filling improved to high or medium grades.
CONCLUSIONS: The results suggest that advancing age apparently affects the development of collateral formation through the indirect bypass. Consequently, direct bypass is thought to be the main treatment option for patients older than 40.

Entities:  

Mesh:

Year:  1996        PMID: 8638240     DOI: 10.1016/0090-3019(95)00475-0

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  19 in total

1.  Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article.

Authors:  Robert M Starke; Ricardo J Komotar; Zachary L Hickman; Yehuda E Paz; Angela G Pugliese; Marc L Otten; Matthew C Garrett; Mitchell S V Elkind; Randolph S Marshall; Joanne R Festa; Philip M Meyers; E Sander Connolly
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

2.  When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.

Authors:  Marcello Scala; Pietro Fiaschi; Valeria Capra; Maria Luisa Garrè; Domenico Tortora; Marcello Ravegnani; Marco Pavanello
Journal:  Childs Nerv Syst       Date:  2018-05-24       Impact factor: 1.475

Review 3.  Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions.

Authors:  Yasuo Nishijima; Yosuke Akamatsu; Phillip R Weinstein; Jialing Liu
Journal:  Brain Res       Date:  2015-03-11       Impact factor: 3.252

4.  Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease.

Authors:  Takeshi Mikami; Hime Suzuki; Ryo Ukai; Katsuya Komatsu; Yukinori Akiyama; Masahiko Wanibuchi; Kiyohiro Houkin; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2019-02-14       Impact factor: 3.042

5.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

6.  Angiographic Characteristics of Cerebral Perfusion and Hemodynamics of the Bridging Artery After Surgical Treatment of Unilateral Moyamoya Disease.

Authors:  Kun Zhang; Wei Ren; Yu-Xue Sun; Xin-Jun Wang; Chao-Yue Li; Zi-Liang Wang; Tian-Xiao Li; Bu-Lang Gao
Journal:  Front Neurosci       Date:  2022-06-14       Impact factor: 5.152

7.  Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures.

Authors:  Jinbing Zhao; Hongyi Liu; Yuanjie Zou; Wenbin Zhang; Shengxue He
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

8.  Neoangiogenesis in association with moyamoya syndrome shown by estimation of relative recirculation based on dynamic contrast-enhanced MR images.

Authors:  Andrea Kassner; Xiao-Ping Zhu; Kah-Lo Li; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

9.  2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.

Authors:  Miki Fujimura; Teiji Tominaga; Satoshi Kuroda; Jun C Takahashi; Hidenori Endo; Kuniaki Ogasawara; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-02-22       Impact factor: 2.036

Review 10.  Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?

Authors:  Ignazio G Vetrano; Anna Bersano; Isabella Canavero; Francesco Restelli; Gabriella Raccuia; Elisa F Ciceri; Giuseppe Faragò; Andrea Gioppo; Morgan Broggi; Marco Schiariti; Laura Gatti; Paolo Ferroli; Francesco Acerbi
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.